CDT Equity Inc, Financials
This page shows CDT Equity Inc, (CDTTW) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 4 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →
Health score ≠ stock price. This rates the quality of CDT Equity Inc,'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
CDT Equity Inc,'s current ratio of 0.34 is below the typical benchmark, resulting in a score of 1/100. This tight liquidity could limit financial flexibility if cash inflows slow.
Key Financial Metrics
Earnings & Revenue
CDT Equity Inc, earned $-1177.89 per diluted share (EPS) in fiscal year 2025. This represents an increase of 98.1% from the prior year.
Cash & Balance Sheet
CDT Equity Inc, held $1.5M in cash against $0 in long-term debt as of fiscal year 2025.
CDT Equity Inc, had 92,140 shares outstanding in fiscal year 2025. This represents an increase of 19887.0% from the prior year.
Margins & Returns
Capital Allocation
CDT Equity Inc, invested $5.1M in research and development in fiscal year 2025. This represents an increase of 49.6% from the prior year.
CDT Equity Inc, spent $106K on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding.
CDTTW Income Statement
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | N/A | $1.5M-17.6% | $1.9M+103.1% | $916K | N/A | $3.1M+12272.0% | $25K-80.5% | $128K |
| SG&A Expenses | N/A | $5.5M+77.9% | $3.1M+14.5% | $2.7M | N/A | $2.7M-12.7% | $3.1M+10.2% | $2.8M |
| Operating Income | N/A | -$7.0M-42.0% | -$5.0M-36.9% | -$3.6M | N/A | -$5.8M-85.1% | -$3.1M-6.3% | -$3.0M |
| Interest Expense | N/A | $100K0.0% | $100K0.0% | $100K | N/A | $49K+22.5% | $40K-66.4% | $119K |
| Income Tax | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income | N/A | -$7.1M-18.1% | -$6.0M-26.8% | -$4.8M | N/A | -$6.5M-20.0% | -$5.4M-51.5% | -$3.6M |
| EPS (Diluted) | N/A | $-13.16-141.0% | $-5.46-347.5% | $-1.22 | N/A | $-889.58-713.7% | $-109.33-2173.0% | $-4.81 |
CDTTW Balance Sheet
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $5.7M-33.9% | $8.6M+7.0% | $8.0M+3.6% | $7.7M+84.0% | $4.2M+40.1% | $3.0M-9.4% | $3.3M-32.8% | $4.9M |
| Current Assets | $4.4M-38.3% | $7.1M+11.1% | $6.4M+7.3% | $5.9M+119.1% | $2.7M+94.3% | $1.4M-12.7% | $1.6M-49.3% | $3.2M |
| Cash & Equivalents | $1.5M-60.7% | $3.8M+15.2% | $3.3M+56.4% | $2.1M+284.5% | $554K+680.3% | $71K-67.6% | $219K-88.1% | $1.8M |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $12.8M+200.0% | $4.3M-4.2% | $4.5M-3.8% | $4.6M-57.8% | $11.0M-9.3% | $12.1M+38.1% | $8.8M+9.4% | $8.0M |
| Current Liabilities | $12.8M+200.6% | $4.3M-3.4% | $4.4M-3.0% | $4.5M-57.7% | $10.7M-10.3% | $12.0M+39.4% | $8.6M+11.3% | $7.7M |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | -$7.2M-267.6% | $4.3M+21.2% | $3.5M+14.6% | $3.1M+145.3% | -$6.8M+25.5% | -$9.1M-66.9% | -$5.5M-76.3% | -$3.1M |
| Retained Earnings | -$68.3M-45.4% | -$47.0M-17.8% | -$39.9M-17.8% | -$33.9M-16.3% | -$29.1M-9.0% | -$26.7M-31.9% | -$20.2M-36.2% | -$14.9M |
CDTTW Cash Flow Statement
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$4.6M-5.1% | -$4.4M-70.9% | -$2.6M+34.3% | -$3.9M-3.0% | -$3.8M-90.7% | -$2.0M-32.1% | -$1.5M+35.8% | -$2.4M |
| Capital Expenditures | N/A | -$7K-800.0% | $1K-99.8% | $404K | $0-100.0% | $41K | N/A | N/A |
| Free Cash Flow | N/A | -$4.4M-71.1% | -$2.6M+40.4% | -$4.3M-13.6% | -$3.8M-86.9% | -$2.0M | N/A | N/A |
| Investing Cash Flow | $595K+159.6% | -$998K-99700.0% | -$1K+99.8% | -$404K-575.3% | $85K-11.5% | $96K | N/A | N/A |
| Financing Cash Flow | $1.7M-71.0% | $6.0M+59.6% | $3.8M-36.6% | $5.9M+40.8% | $4.2M+141.4% | $1.7M | N/A | N/A |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
CDTTW Financial Ratios
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity | N/A | -166.4%+4.4pp | -170.8%-16.5pp | -154.3% | N/A | N/A | N/A | N/A |
| Return on Assets | N/A | -83.2%-7.8pp | -75.4%-13.8pp | -61.6% | N/A | -215.9%-53.0pp | -162.9%-90.6pp | -72.2% |
| Current Ratio | 0.34-1.3 | 1.66+0.2 | 1.45+0.1 | 1.31+1.1 | 0.25+0.1 | 0.12-0.1 | 0.19-0.2 | 0.41 |
| Debt-to-Equity | -1.79-2.8 | 1.00-0.3 | 1.26-0.2 | 1.50+3.1 | -1.62-0.3 | -1.33+0.3 | -1.61+1.0 | -2.59 |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Note: Shareholder equity is negative (-$7.2M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.34), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Frequently Asked Questions
What is CDT Equity Inc,'s operating cash flow?
CDT Equity Inc, (CDTTW) generated -$15.6M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are CDT Equity Inc,'s total assets?
CDT Equity Inc, (CDTTW) had $5.7M in total assets as of fiscal year 2025, including both current and long-term assets.
How much does CDT Equity Inc, spend on research and development?
CDT Equity Inc, (CDTTW) invested $5.1M in research and development during fiscal year 2025.
What is CDT Equity Inc,'s current ratio?
CDT Equity Inc, (CDTTW) had a current ratio of 0.34 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
What is CDT Equity Inc,'s debt-to-equity ratio?
CDT Equity Inc, (CDTTW) had a debt-to-equity ratio of -1.79 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is CDT Equity Inc,'s cash runway?
Based on fiscal year 2025 data, CDT Equity Inc, (CDTTW) had $1.5M in cash against an annual operating cash burn of $15.6M. This gives an estimated cash runway of approximately 1 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
Why is CDT Equity Inc,'s debt-to-equity ratio negative or unusual?
CDT Equity Inc, (CDTTW) has negative shareholder equity of -$7.2M as of fiscal year 2025, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
How financially healthy is CDT Equity Inc,?
CDT Equity Inc, (CDTTW) scores 0 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.